DudeMeds vs Ro: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent researchHow we rank →

DudeMeds beats Ro overall, scoring 7.8/10 vs 7.2/10. Choose DudeMeds for men who want glp-1 weight loss from a men's health-focused p. Choose Ro for users who want fda-approved brand-name glp-1 access includin.

A side-by-side comparison of DudeMeds and Ro covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

DudeMeds

#15 of 48
7.8/10

Men's health telehealth platform offering compounded GLP-1 medications tailored to male patients.

Visit DudeMeds

Ro

#44 of 48
7.2/10

One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.

Visit Ro
FeatureDudeMedsRo
Our Score7.8/107.2/10
Starting Price$149/mo$149/mo
Medication TypeCompoundedBrand
Insurance AcceptedNoYes
Best ForMen who want GLP-1 weight loss from a men's health-focused platformUsers who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing
Ranking#15#44

Pros & Cons Compared

DudeMeds

Pros

  • +Simplest all-in pricing: $199/mo flat covering medication, consultation, and free shipping — zero hidden fees
  • +48-hour medication shipping — among the fastest fulfillment times in the industry
  • +No doctor visit required in most states — maximally convenient for patients who don't want appointments
  • +Serves both men and women despite the brand name

Cons

  • No video or phone consultation in most states — minimal clinical oversight compared to platforms with regular check-ins
  • No publicly disclosed headquarters, founding date, or pharmacy partners — lack of transparency
  • Limited online review presence makes it difficult to verify patient satisfaction claims

Ro

Pros

  • +Carries Foundayo (orforglipron) — Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026 — at $149-299/mo via LillyDirect matching
  • +Direct insurance billing with major carriers — with coverage, Wegovy or Zepbound can cost $0-25/mo copay
  • +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
  • +Claims matched pricing with LillyDirect, NovoCare, and TrumpRx — some of the lowest cash brand prices available

Cons

  • Membership and medication are billed separately — readers need to add them together for the all-in monthly cost
  • Brand-name only — no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
  • Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)

Our Verdict

DudeMeds edges out Ro with a score of 7.8/10 vs 7.2/10. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. Choose DudeMeds if you want: men who want glp-1 weight loss from a men's health-focused platform. Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither DudeMeds nor Ro feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try DudeMeds

Starting at $149/mo

Visit DudeMeds

Try Ro

Starting at $149/mo

Visit Ro

Related comparisons

Other matchups readers comparing DudeMeds or Ro tend to look at next.

Top Picks

Four programs our readers click through most.

Eden Health GLP-1

8.9/10
$249/mo·Brand & Compounded

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.